Cytokine induced tumor killer cell therapy (Hongyuan Yishi Biotechnology Pharmaceutical)
细胞因子诱导人外周血获得的人肿瘤杀伤细胞（东莞宏远逸士生物技术药业）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameCytokine induced tumor killer cell therapy (Hongyuan Yishi Biotechnology Pharmaceutical)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesDongguan Hongyuan Yishi Biotechnology Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesDongguan Hongyuan Yishi Biotechnology Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A